Why Sotera Health Co’s (SHC) Stock Is Down 10.14%

By Jenna Brashear
March 20, 2024
Featured Tickers:
SHC

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Sotera Health Co before investing.

In this article, we go over a few key elements for understanding Sotera Health Co’s stock price such as:

  • Sotera Health Co’s current stock price and volume
  • Why Sotera Health Co’s stock price changed recently
  • Upgrades and downgrades for SHC from analysts
  • SHC’s stock price momentum as measured by its relative strength

About Sotera Health Co (SHC)

Before we jump into Sotera Health Co’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Sotera Health Company is a global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. The Company’s segments include Sterigenics, Nordion, and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. The Nordion business is a provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and materials industries and for the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. The Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.

Want to learn more about Sotera Health Co’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Sotera Health Co.

Learn More About A+ Investor

Sotera Health Co’s Stock Price as of Market Close

As of March 20, 2024, 4:00 PM, CST, Sotera Health Co’s stock price was $11.78.

Sotera Health Co is down 10.14% from its previous closing price of $13.11.

During the last market session, Sotera Health Co’s stock traded between $13.05 and $14.47. Currently, there are 281.34 million shares of Sotera Health Co stock available for purchase.

Sotera Health Co’s price-earnings (P/E) ratio is currently at 72.7, which is high compared to the Healthcare Facilities & Services industry median of 24. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Sotera Health Co Stock Price History

Sotera Health Co’s (SHC) price is currently down 21.52% so far this month.

During the month of March, Sotera Health Co’s stock price has reached a high of $15.03 and a low of $10.74.

Over the last year, Sotera Health Co has hit prices as high as $19.40 and as low as $12.34. Year to date, Sotera Health Co’s stock is up 41.42%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Sotera Health Co Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of March 19, 2024, there were 4 analysts who downgraded Sotera Health Co’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Sotera Health Co’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Sotera Health Co’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Sotera Health Co’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Sotera Health Co (SHC) by visiting AAII Stock Evaluator.

Relative Price Strength of Sotera Health Co

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of March 19, 2024, Sotera Health Co has a weighted four-quarter relative price strength of -15.39%, which translates to a Momentum Score of 23 and is considered to be Weak.

Want to learn more about how Sotera Health Co is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Sotera Health Co Stock Price: Bottom Line

As of March 20, 2024, Sotera Health Co’s stock price is $11.78, which is down 10.14% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Sotera Health Co stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
High Relative Dividend
Yield Screen:
8.7% Compared to S&P 500
at only 6.9%

Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.